Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Annals of Internal Medicine
|
October 22, 2008
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial
Gérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|
February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]
Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Journal of the American College of Cardiology
|
December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertension
Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
The Lancet. Neurology
|
April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial
Elia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|
February 21, 2015
[Pediatric pulmonary hypertension]
D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
Therapeutic Innovation & Regulatory Science
|
September 3, 2022
Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
Thomas R Fleming, Christine E Garnett, Laurie S Conklin, et al.
Journal of the American College of Cardiology
|
December 21, 2013
Pediatric pulmonary hypertension
D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
Leukemia & Lymphoma
|
August 15, 2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)
Francis J Giles, Carole B Miller, David D Hurd, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 30, 2005
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia
Marin Kollef, Didier Pittet, Miguel Sánchez García, et al.
JACC. Heart Failure
|
March 26, 2024
Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
Thomas R Fleming, Janet Wittes, Mona Fiuzat, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Annals of Internal Medicine
|
October 22, 2008
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial
Gérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|
February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]
Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Journal of the American College of Cardiology
|
December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertension
Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
The Lancet. Neurology
|
April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial
Elia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|
February 21, 2015
[Pediatric pulmonary hypertension]
D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
Therapeutic Innovation & Regulatory Science
|
September 3, 2022
Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
Thomas R Fleming, Christine E Garnett, Laurie S Conklin, et al.
Journal of the American College of Cardiology
|
December 21, 2013
Pediatric pulmonary hypertension
D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
Leukemia & Lymphoma
|
August 15, 2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)
Francis J Giles, Carole B Miller, David D Hurd, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 30, 2005
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia
Marin Kollef, Didier Pittet, Miguel Sánchez García, et al.
JACC. Heart Failure
|
March 26, 2024
Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
Thomas R Fleming, Janet Wittes, Mona Fiuzat, et al.
Page
of 11